共 50 条
- [3] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye [J]. CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
- [8] A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom [J]. Advances in Therapy, 2017, 34 : 703 - 712
- [9] Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD) [J]. BMJ OPEN OPHTHALMOLOGY, 2024, 9 (01):